SymTrend — Belmont, Massachusetts

SymTrend is a clinical research site located in Belmont, Massachusetts, United States 02478.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

SymTrend has participated in 2 clinical trials.

Therapeutic areas: Asperger Syndrome, High Functioning Autism, Autism.

Sponsors: Minna Levine, PhD, SymTrend Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Belmont

Browse all research sites in Massachusetts · View every site in Belmont

• Obsessive Compulsive Disorder Institute at McLean Hospital
• McLean Hospital, Harvard Medical School, Department of Psychiatry
• McLean Hospital Neuroimaging Center, 115 Mill Street
• McLean Hospital Geriatric Psychiatry
• Harvard University/McLean Hospital
• McLean Hospital Harvard Medical School
• McLean Hospital, Alcohol and Drug Abuse Treatment Program
• McLean Hospital
• McLean Hospital Brain Imaging Center
• McLean Hospital - TMS Services
• Mclean Hospital Imaging Center
• McLean Hospital OnTrack Clinic

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SymTrend?

SymTrend has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SymTrend conducted?

SymTrend has 2 clinical trials on record. Their work covers Asperger Syndrome, High Functioning Autism, Autism.

Is SymTrend accredited by Crixeo Clinical Trials?

SymTrend has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SymTrend?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.